Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""neoplasm recurrence, local"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 14442
Tytuł:
Operative treatment of pulmonary primitive neuroectodermal tumor: a case report and literature review.
Autorzy:
Zhang Y; Department of Thoracic surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Shang K; Department of Anesthesiology, The First Hospital of Jilin University, Changchun, 130021, China.
Li J; Department of Thoracic surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Sun M; Department of Cardial Surgery, The First Hospital of Jilin University, Changchun, 130021, China.
Gu X; Department of Anesthesiology, The First Hospital of Jilin University, Changchun, 130021, China. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2024 Mar 05; Vol. 19 (1), pp. 109. Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Neuroectodermal Tumors, Primitive*/diagnosis
Neuroectodermal Tumors, Primitive*/surgery
Female ; Humans ; Child ; Pneumonectomy ; Neoadjuvant Therapy ; Lung
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Survival Analysis of Patients with Recurrent Epithelial Ovarian Cancer Based on Relapse Type: A Multi-Institutional Retrospective Study in Armenia.
Autorzy:
Harutyunyan L; Department of General Oncology, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.; Oncology Clinic, Mikaelyan Institute of Surgery, Ezras Hasratian 9, Yerevan 0052, Armenia.
Manvelyan E; Department of Reproductive Biology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Karapetyan N; Department of General Oncology, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.; Clinic of Adults' Oncology and Chemotherapy at Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.; Immune Oncology Research Institute, 7 Nersisyan St., Yerevan 0014, Armenia.; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.
Bardakhchyan S; Clinic of Adults' Oncology and Chemotherapy at Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.; Immune Oncology Research Institute, 7 Nersisyan St., Yerevan 0014, Armenia.; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.
Jilavyan A; National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.; Department of Gynecologic Oncology, National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.
Tamamyan G; Immune Oncology Research Institute, 7 Nersisyan St., Yerevan 0014, Armenia.; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.; Pediatric Cancer and Blood Disorders Center of Armenia, 7 Nersisyan St., Yerevan 0014, Armenia.; Pediatric Oncology and Hematology Department, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.
Avagyan A; Department of General Oncology, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.; Oncology Clinic, Mikaelyan Institute of Surgery, Ezras Hasratian 9, Yerevan 0052, Armenia.
Safaryan L; Clinic of Adults' Oncology and Chemotherapy at Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.
Zohrabyan D; Clinic of Adults' Oncology and Chemotherapy at Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.
Movsisyan N; Department of General Oncology, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.; Oncology Clinic, Mikaelyan Institute of Surgery, Ezras Hasratian 9, Yerevan 0052, Armenia.; Anesthesiology and Intensive Care Department, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.; Armenian Association for the Study of Pain, 12 Kievyan Str. Apt. 20, Yerevan 0028, Armenia.
Avinyan A; Oncology Clinic, Mikaelyan Institute of Surgery, Ezras Hasratian 9, Yerevan 0052, Armenia.
Galoyan A; Oncology Clinic, Mikaelyan Institute of Surgery, Ezras Hasratian 9, Yerevan 0052, Armenia.
Sargsyan M; Oncology Clinic, Mikaelyan Institute of Surgery, Ezras Hasratian 9, Yerevan 0052, Armenia.; Immune Oncology Research Institute, 7 Nersisyan St., Yerevan 0014, Armenia.
Harutyunyan M; Clinic of Adults' Oncology and Chemotherapy at Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.
Nersoyan H; National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.; Clinical Research and Cancer Registry Department, National Center of Oncology after V.A. Fanarjian, 76 Fanarjyan St., Yerevan 0052, Armenia.
Stepanyan A; National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.; Clinical Research and Cancer Registry Department, National Center of Oncology after V.A. Fanarjian, 76 Fanarjyan St., Yerevan 0052, Armenia.
Galstyan A; National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.; Diagnostic Service of the National Center of Oncology, 76 Fanarjyan St., Yerevan 0052, Armenia.
Danielyan S; Yeolyan Hematology and Oncology Center, 7 Nersisyan St., Yerevan 0014, Armenia.
Muradyan A; Department of General Oncology, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.
Jilavyan G; Department of General Oncology, Yerevan State Medical University after M. Heratsi, 2 Koryun St., Yerevan 0025, Armenia.; National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.; Department of Gynecologic Oncology, National Center of Oncology of Armenia, 76 Fanarjyan St., Yerevan 0052, Armenia.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Mar 04; Vol. 31 (3), pp. 1323-1334. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Ovarian Neoplasms*/drug therapy
Humans ; Female ; Carcinoma, Ovarian Epithelial ; Retrospective Studies ; Case-Control Studies ; Armenia ; Survival Analysis ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study.
Autorzy:
Awan AA; Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.; Cancer Therapeutics Program, Ottawa Hospital Research Institute and Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Saunders D; Cancer Therapeutics Program, Ottawa Hospital Research Institute and Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Pond G; Department of Oncology, McMaster University, Hamilton, ON L8S 4L8, Canada.
Hamm C; Windsor Regional Hospital, Windsor, ON N9A 1E1, Canada.
Califaretti N; Grand River Regional Cancer Centre, Kitchener, ON N2G 1G3, Canada.
Mates M; Kingston Health Sciences Centre, Kingston, ON K7L 5G2, Canada.
Kumar V; Markham Stouffville Hospital, Markham, ON L3P 7P3, Canada.
Ibrahim MFK; Division of Oncology, Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada.
Beltran-Bless AA; Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Vandermeer L; Cancer Therapeutics Program, Ottawa Hospital Research Institute and Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Hilton J; Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.; Cancer Therapeutics Program, Ottawa Hospital Research Institute and Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Clemons M; Division of Medical Oncology and Department of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.; Cancer Therapeutics Program, Ottawa Hospital Research Institute and Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 27; Vol. 31 (3), pp. 1278-1290. Date of Electronic Publication: 2024 Feb 27.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Breast Neoplasms*/drug therapy
Humans ; Female ; Prospective Studies ; Risk ; Ontario
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Papillary Thyroid Microcarcinoma: Differences between Lesions in Incidental and Nonincidental Settings-Considerations on These Clinical Entities and Personal Experience.
Autorzy:
Lucandri G; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Fiori G; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Falbo F; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Pende V; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Farina M; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Mazzocchi P; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Santonati A; Endocrinologic and Metabolic Departmental Ward Unit, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Bosco D; Endocrinologic and Metabolic Departmental Ward Unit, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Spada A; Endocrinologic and Metabolic Departmental Ward Unit, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Santoro E; Department of Surgical Oncology, San Giovanni-Addolorata Hospital, Via Dell'Amba Aradam 9, 00184 Rome, Italy.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Feb 06; Vol. 31 (2), pp. 941-951. Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Thyroid Neoplasms*/diagnosis
Carcinoma, Papillary*
Humans ; Male ; Female ; Retrospective Studies ; Incidental Findings
SCR Disease Name:
Papillary Thyroid Microcarcinoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial.
Autorzy:
Kim KH; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Lim SM; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Ahn HK; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Keam B; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kim HR; Divison of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Lee HW; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.
An HJ; Division of Medical Oncology, Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.
Kim JS; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 37-47. Date of Electronic Publication: 2023 Jul 20.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Indoles*
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Precision Medicine ; Antineoplastic Combined Chemotherapy Protocols
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Meta analysis of the second course of radiotherapy for recurrent esophageal cancer1.
Autorzy:
Xu P; Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Liu Y; Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wu S; Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cheng D; Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Sun Z; Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Journal of X-ray science and technology [J Xray Sci Technol] 2024; Vol. 32 (1), pp. 141-155.
Typ publikacji:
Meta-Analysis; Review; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/radiotherapy
Esophageal Neoplasms*/drug therapy
Esophageal Neoplasms*/radiotherapy
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical implication of genetic intratumor heterogeneity for targeted therapy in head and neck cancer.
Autorzy:
Gram SB; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Alosi D; Center for Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Bagger FO; Center for Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Østrup O; Center for Genomic Medicine, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
von Buchwald C; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Friborg J; Department of Oncology, Section of Radiotherapy, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Wessel I; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Vogelius IR; Department of Oncology, Section of Radiotherapy, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Rohrberg K; Department of Oncology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Rasmussen JH; Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1831-1839. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/genetics
Humans ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Prospective Studies ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
Autorzy:
Liu T; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.; Breast Disease Center, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Dong D; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Zhao X; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Ou XM; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yi JL; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guan J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhang Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiao-Fei L; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Radiology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Xie CM; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Radiology, Sun Yat-Sen University Cancer Center, Guangzhou, China.
Luo DH; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Sun R; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Chen QY; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Xing L; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Guo SS; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Liu LT; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Lin DF; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Chen YZ; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Lin JY; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Luo MJ; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Yan WB; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
He ML; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Mao MY; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhu MY; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China.
Chen WH; Department of Oncology, the First Affiliated Hospital, Jinan University, Guangzhou, China.
Shen BW; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Wang SQ; Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
Li HL; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Zhong LZ; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China.; School of Artificial Intelligence, University of Chinese Academy of Sciences, Beijing, China.
Hu CS; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wu DH; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Mai HQ; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China. .
Tian J; CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. .; Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China. .
Tang LQ; Sun Yat-Sen University Cancer CenterState Key Laboratory of Oncology in South ChinaCollaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, China. .; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Nov 27; Vol. 21 (1), pp. 464. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*/diagnostic imaging
Neoplasm Recurrence, Local*/genetics
Nasopharyngeal Neoplasms*/diagnostic imaging
Nasopharyngeal Neoplasms*/genetics
Nasopharyngeal Neoplasms*/radiotherapy
Humans ; Nasopharyngeal Carcinoma/genetics ; Retrospective Studies ; Prognosis ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.
Autorzy:
Fang Y; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Department of Oncology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
Su N; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Department of Oncology, Guangzhou Chest Hospital, Guangzhou, 510095, People's Republic of China.
Zou Q; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Cao Y; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Xia Y; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Tang L; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Tian X; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Liu P; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Cai Q; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .; State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2023 Nov 07; Vol. 21 (1), pp. 423. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/pathology
Nasopharyngeal Neoplasms*/drug therapy
Nasopharyngeal Neoplasms*/pathology
Humans ; Nasopharyngeal Carcinoma/drug therapy ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint.
Autorzy:
Liu Y; Department of Oral & Maxillofacial Head & Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
Huang Y; Department of Oral & Maxillofacial Head & Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Stomatology Oral maxillofacial Head and Neck Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Zhu D; Department of Oral & Maxillofacial Head & Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Stomatology Oral maxillofacial Head and Neck Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Li J; Department of Oral Pathology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhao T; Department of Oral & Maxillofacial Head & Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Department of Stomatology Oral maxillofacial Head and Neck Surgery, Huashan Hospital, Fudan University, Shanghai, China.
He Y; Biostatistics Office of Clinical Research Unit, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Xia R; Department of Oral Pathology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .
Zhong L; Department of Oral & Maxillofacial Head & Neck Oncology, Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China. .; Department of Stomatology Oral maxillofacial Head and Neck Surgery, Huashan Hospital, Fudan University, Shanghai, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Nov 03; Vol. 23 (1), pp. 1062. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/epidemiology
Neoplasm Recurrence, Local*/pathology
Giant Cell Tumor of Tendon Sheath*/pathology
Humans ; Retrospective Studies ; Macrophage Colony-Stimulating Factor ; Ki-67 Antigen ; China ; Temporomandibular Joint/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination strategy exploration for prior treated recurrent or metastatic nasopharyngeal carcinoma in the era of immunotherapy.
Autorzy:
Jiang Y; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Chen C; Department of Nuclear Medicine, The Seventh Affiliated Hospital of Sun Yat-sen University, 628 Zhenyuan Road, Shenzhen, 518107, People's Republic of China.
Liu G; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Department of Radiotherapy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
Fang T; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Lu N; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.; Department of Radiology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Bei W; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Dong S; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Li W; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China.
Xia W; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .
Liang H; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .
Xiang Y; Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Jan 20; Vol. 14 (1), pp. 1768. Date of Electronic Publication: 2024 Jan 20.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Nasopharyngeal Neoplasms*/drug therapy
Humans ; Nasopharyngeal Carcinoma/drug therapy ; Retrospective Studies ; Irinotecan ; Immunotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines.
Autorzy:
Lee B; Department of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.
Chang SJ; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. .
Kwon BS; Department of Obstetrics and Gynecology, Kyung Hee University Medical Center, School of Medicine, Kyung Hee University, Seoul, Korea.
Son JH; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.
Lim MC; Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Kim YH; Department of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
Lee SW; Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Choi CH; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Eoh KJ; Department of Obstetrics and Gynecology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.
Lee JY; Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
Suh DH; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
Kim YB; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
Pokaż więcej
Źródło:
Journal of gynecologic oncology [J Gynecol Oncol] 2024 Jan; Vol. 35 (1), pp. e43. Date of Electronic Publication: 2023 Dec 27.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/drug therapy
Ovarian Neoplasms*/drug therapy
Female ; Humans ; Bevacizumab/adverse effects ; Carcinoma, Ovarian Epithelial/drug therapy ; Republic of Korea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox.
Autorzy:
Moufarrij S; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
O'Cearbhaill RE; Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY 10065, USA.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 23; Vol. 31 (1), pp. 97-114. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasm Recurrence, Local*
Ovarian Neoplasms*/drug therapy
Humans ; Female ; Carcinoma, Ovarian Epithelial ; Bevacizumab ; Therapies, Investigational ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning based prediction of recurrence after curative resection for rectal cancer.
Autorzy:
Jeon Y; Department of Surgery, Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Kim YJ; Department of Biomedical Engineering, Gachon University, Incheon, South Korea.
Jeon J; Department of Biomedical Engineering, Gachon University, Incheon, South Korea.
Nam KH; Department of Surgery, Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Hwang TS; Department of Surgery, Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Kim KG; Department of Biomedical Engineering, Gachon University, Incheon, South Korea.
Baek JH; Department of Surgery, Division of Colon and Rectal Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon, South Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 15; Vol. 18 (12), pp. e0290141. Date of Electronic Publication: 2023 Dec 15 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Rectal Neoplasms*/surgery
Rectal Neoplasms*/pathology
Humans ; Rectum/pathology ; Chemoradiotherapy ; Machine Learning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Periostin facilitates ovarian cancer recurrence by enhancing cancer stemness.
Autorzy:
Huang Z; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA. .; Department of Obstetrics and Gynecology, Duke University Medical Center, 701 West Main Street, Suite 510, Duke, PO Box 90534, Durham, NC, 27701, USA. .
Byrd O; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Tan S; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Hu K; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Knight B; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Lo G; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Taylor L; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Wu Y; Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics, Duke University, Durham, USA.
Berchuck A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Murphy SK; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Dec 04; Vol. 13 (1), pp. 21382. Date of Electronic Publication: 2023 Dec 04.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*
Ovarian Neoplasms*/genetics
Cell Adhesion Molecules*/genetics
Animals ; Female ; Humans ; Mice ; Cell Line, Tumor ; Disease Progression ; Epithelial-Mesenchymal Transition/genetics ; Phenotype ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.
Autorzy:
Seftel MD; Canadian Blood Services, Vancouver, BC V6H 2N9, Canada.; Division of Hematology, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.
Pasic I; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5G 2M9, Canada.
Parmar G; Canadian Blood Services, Vancouver, BC V6H 2N9, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5G 2M9, Canada.
Bucher O; Department of Epidemiology, CancerCare Manitoba, Winnipeg, MB R3A 1M5, Canada.
Allan DS; Canadian Blood Services, Vancouver, BC V6H 2N9, Canada.; Department of Medicine and Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Bhella S; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5G 2M9, Canada.
Hay KA; Division of Hematology, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada.; Division of Hematology, Department of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.; Terry Fox Laboratory, British Columbia Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Ikuomola O; Department of Epidemiology, CancerCare Manitoba, Winnipeg, MB R3A 1M5, Canada.
Musto G; Department of Epidemiology, CancerCare Manitoba, Winnipeg, MB R3A 1M5, Canada.
Prica A; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5G 2M9, Canada.
Richardson E; Department of Epidemiology, CancerCare Manitoba, Winnipeg, MB R3A 1M5, Canada.
Truong TH; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Calgary, Calgary, AB T3B 6A8, Canada.
Paulson K; Cell Therapy and Transplant Canada, Winnipeg, MB R3E 0V9, Canada.; Department of Medical Oncology and Haematology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Nov 17; Vol. 30 (11), pp. 9953-9967. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Neoplasm Recurrence, Local*
Aged ; Child ; Humans ; Cohort Studies ; Registries ; Retrospective Studies ; Transplantation, Homologous ; Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
Autorzy:
Sugawara K; Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, 780 Komuro Inamachi, Kitaadachi-gun, Saitama, 362-0806, Japan. .
Oka D; Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, 780 Komuro Inamachi, Kitaadachi-gun, Saitama, 362-0806, Japan.
Hara H; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
Yoshii T; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
Ushijima H; Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.
Kudo S; Department of Radiation Oncology, Saitama Cancer Center, Saitama, Japan.
Fukuda T; Department of Gastroenterological Surgery, Saitama Cancer Center Hospital, 780 Komuro Inamachi, Kitaadachi-gun, Saitama, 362-0806, Japan.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Nov 01; Vol. 23 (1), pp. 1051. Date of Electronic Publication: 2023 Nov 01.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Esophageal Neoplasms*/pathology
Humans ; Prognosis ; Retrospective Studies ; Combined Modality Therapy ; Chemoradiotherapy ; Esophagectomy ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Usefulness of Elastin Staining to Detect Vascular Invasion in Cancer.
Autorzy:
Gonzalez J; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Bahmad HF; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Ocejo S; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Abreu A; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Popp M; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Gogola S; Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Fernandez V; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Recine M; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.; Department of Pathology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Poppiti R; Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.; Department of Pathology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 17; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Elastin*
Neoplasm Recurrence, Local*
Humans ; Male ; Female ; Antibodies, Monoclonal, Murine-Derived ; Neoplasm Invasiveness/pathology ; Staining and Labeling ; Biomarkers, Tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Autorzy:
Liu R; Department of Cell and Cancer Biology, College of Medicine and Life Sciences, the University of Toledo, 3000 Transverse Drive, Toledo, OH, 43614, USA.
Su S; Department of Cell and Cancer Biology, College of Medicine and Life Sciences, the University of Toledo, 3000 Transverse Drive, Toledo, OH, 43614, USA.
Xing J; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Liu K; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Zhao Y; Department of Cell and Cancer Biology, College of Medicine and Life Sciences, the University of Toledo, 3000 Transverse Drive, Toledo, OH, 43614, USA.
Stangis M; Department of Cell and Cancer Biology, College of Medicine and Life Sciences, the University of Toledo, 3000 Transverse Drive, Toledo, OH, 43614, USA.
Jacho DP; Bioengineering Department, the University of Toledo, Toledo, OH, 43606, USA.
Yildirim-Ayan ED; Bioengineering Department, the University of Toledo, Toledo, OH, 43606, USA.
Gatto-Weis CM; Department of Pathology, College of Medicine and Life Sciences, the University of Toledo, Toledo, OH, 43614, USA.
Chen B; Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA. .; Department of Pharmacology and Toxicology, Michigan State University, Grand Rapids, MI, 49503, USA. .
Li X; Department of Cell and Cancer Biology, College of Medicine and Life Sciences, the University of Toledo, 3000 Transverse Drive, Toledo, OH, 43614, USA. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Oct 11; Vol. 42 (1), pp. 264. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/metabolism
Prostatic Neoplasms*/pathology
Male ; Humans ; Animals ; Mice ; Focal Adhesion Protein-Tyrosine Kinases/metabolism ; Osteoblasts/metabolism ; Osteoblasts/pathology ; Recurrence ; Cell Line, Tumor ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient Derived Xenografts (PDX) Models as an Avatar to Assess Personalized Therapy Options in Uveal Melanoma: A Feasibility Study.
Autorzy:
Nemati F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University Paris, 26 rue d'Ulm, CEDEX 05, 75248 Paris, France.
de Koning L; Translational Research Department, Institut Curie, PSL University Paris, 75248 Paris, France.
Gentien D; Genomics Platform, Translational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
Assayag F; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University Paris, 26 rue d'Ulm, CEDEX 05, 75248 Paris, France.
Henry E; Genomics Platform, Translational Research Department, Institut Curie, PSL Research University, 75248 Paris, France.
Ait Rais K; Department of Genetics, Institut Curie, PSL Research University, 75248 Paris, France.
Pierron G; Department of Genetics, Institut Curie, PSL Research University, 75248 Paris, France.
Mariani O; Biological Resource Center, Department of Pathology, Institut Curie, PSL Research University, 75248 Paris, France.
Nijnikoff M; Biological Resource Center, Department of Pathology, Institut Curie, PSL Research University, 75248 Paris, France.
Champenois G; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
Nicolas A; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
Meseure D; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
Gardrat S; Department of Biopathology, Institut Curie, PSL Research University, 75248 Paris, France.
Servant N; Institut Curie, INSERM U900, CBIO-Centre for Computational Biology, Mines Paris Tech, PSL-Research University, 75248 Paris, France.
Hupé P; Institut Curie, INSERM U900, CBIO-Centre for Computational Biology, Mines Paris Tech, PSL-Research University, 75248 Paris, France.
Kamal M; Department of Drug Development and Innovation (D3i), Institut Curie, 75248 Paris, France.
Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, 75248 Paris, France.; INSERM U900 Research Unit, Institut Curie, 92064 Saint-Cloud, France.; Paris-Saclay University, 75248 Paris, France.
Piperno-Neumann S; Department of Medical Oncology, Institut Curie, PSL Research University, 75248 Paris, France.
Rodrigues M; Department of Medical Oncology, Institut Curie, PSL Research University, 75248 Paris, France.
Roman-Roman S; Translational Research Department, Institut Curie, PSL University Paris, 75248 Paris, France.
Decaudin D; Laboratory of Preclinical Investigation, Translational Research Department, Institut Curie, PSL University Paris, 26 rue d'Ulm, CEDEX 05, 75248 Paris, France.; Department of Medical Oncology, Institut Curie, PSL Research University, 75248 Paris, France.
Mariani P; Department of Surgical Oncology, Institut Curie, PSL Research University, 75248 Paris, France.
Cassoux N; Department of Oncological Ophthalmology, Institut Curie, Université Paris Cité, 75248 Paris, France.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Oct 11; Vol. 30 (10), pp. 9090-9103. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*
Liver Neoplasms*/genetics
Adult ; Animals ; Mice ; Humans ; Feasibility Studies ; Heterografts ; Mice, SCID ; Recurrence
SCR Disease Name:
Uveal melanoma
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 14442

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies